Lansoprazole Capsule, Delayed Release
Product Images NDC 0536-1368

2 FDA label images from Rugby Laboratories, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 0536-1368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Container (Container)
Label for Lansoprazole 15 mg delayed-release capsules by Rugby Laboratories. The label identifies the product as an acid reducer with a 24-hour effect and mentions a package count of 14 capsules. The label includes tamper-evident warnings, distributor information, a barcode, and instructions to see the carton for complete product details.*
FDA Label Image

42ct Carton (Rugby Lanso Caps 42ct Carton Label)

42ct Carton (Rugby Lanso Caps 42ct Carton Label)
Packaging label for Lansoprazole 15 mg delayed-release capsules by Rugby Laboratories, Inc. The label indicates 42 capsules per bottle, equivalent to three 14-day treatment courses. The product is labeled as an acid reducer for frequent heartburn. The label includes directions, warnings, inactive ingredients, and contact information for Rugby Laboratories, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.